References
- Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998; 351: 659–664
- Touitou I. The spectrum of Familial Mediterranean fever (FMF) mutations. Eur J Hum Genet 2001; 9: 473–483
- Onen F. Familial Mediterranean fever. Rheumatol Int 2006; 26: 489–496
- Ben-Chetrit E, Touitou I. Familial Mediterranean fever in the world. Arthritis Rheum 2009; 61: 1447–1453
- Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Toms TE, Douglas KM, Kitas GD. The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 2010; 8: 437–449
- Yüksel S, Ayvazyan L, Gasparyan AY. Familial Mediterranean fever as an emerging clinical model of atherogenesis associated with low-grade inflammation. Open Cardiovasc Med J 2010; 4: 51–56
- Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: A link between thrombosis and inflammation?. Curr Pharm Des 2011; 17: 47–58
- Robbins G, Barnard DL. Thrombocytosis and microthrombocytosis: A clinical evaluation of 372 cases. Acta Haematol 1983; 70: 175–182
- Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: Methodological issues. Platelets 2002; 13: 301–306
- Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002; 117: 399–404
- Bath P, Algert C, Chapman N, Neal B. Progress Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004; 35: 622–626
- Gasparyan AY, Sandoo A, Stavropoulos-Kalinoglou A, Kitas GD. Mean platelet volume in patients with rheumatoid arthritis: The effect of anti-TNF-α therapy. Rheumatol Int. 2010; 30: 1125–1129
- Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA, Kiraz S, Ertenli I, Calguneri M. Mean Platelet Volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 2008; 75: 291–294
- Yuksel O, Helvaci K, Basar O, Koklu S, Caner S, Helvaci N, Abayli E, Altiparmak E. An overlooked indicator of disease activity in ulcerative colitis: Mean platelet volume. Platelets 2009; 20: 277–281
- Makay B, Turkyilmaz Z, Unsal E. Mean platelet volume in children with familial Mediterranean fever. Clin Rheumatol 2009; 28: 975–978
- Arıca S, Ozer C, Arıca V, Karakus A, Celik T, Gunesacar R. Evaluation of the mean platelet volume in children with familial Mediterranean fever. Rheumatol Int 2011, (on-line published: DOI: 10.1007/s00296-011-2251-x)
- Coban E, Adanir H. Platelet activation in patients with Familial Mediterranean fever. Platelets 2008; 19: 405–408
- Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 1879–1885
- Milovanovic M, Nilsson E, Jaremo P. Relationships between platelets and inflammatory markers in rheumatoid arthritis. Clin Chim Acta 2004; 343: 237–240
- Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos SP, Kosmadaki MG, Koutroubakis IE, Kouroumalis EA. Mean platelet volume: A useful marker of inflammatory bowel disease activity. Am J Gastroenterol 2001; 96: 776–781
- Levin J, Bessman JD. The inverse relation between platelet volume and platelet number. J Lab Clin Med 1983; 101: 295–307
- Murphy S. Thrombocytosis and thrombocythaemia. Clin Haematol 1983; 12: 89–106
- Rowan RM, Fraser C, Gray JH, McDonald GA. The Coulter counter model S plus -the shape of things to come. Clin Lab Haematol 1979; 1: 29–40
- Giles C. The platelet count and mean platelet volume. Br J Haematol 1981; 48: 31–37
- Canpolat FE, Yurdakök M, Armangil D, Yiğit S. Mean platelet volume in neonatal respiratory distress syndrome. Pediatr Int 2009; 51: 314–316
- Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Douglas KM, Kitas GD. Platelet function in rheumatoid arthritis: Arthritic and cardiovascular implications. Rheumatol Int 2011; 31: 153–164
- Gasparyan AY, Stavropoulos-Kalinoglou A, Toms TE, Douglas KM, Kitas GD. Association of mean platelet volume with hypertension in rheumatoid arthritis. Inflamm Allergy Drug Targets 2010; 9(1): 45–50
- Kaser A, Brandacher G, Steurer W, Kaser S, Offner FA, Zoller H, Theurl I, Widder W, Molnar C, Ludwiczek O, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: Role in inflammatory thrombocytosis. Blood 2001; 98: 2720–2725
- Clarke D, Johnson PW, Banks RE, Storr M, Kinsey SE, Johnson R, Morgan G, Gordon MY, Illingworth JM, Perren TJ, et al. Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood. Cytokine 1996; 28: 717–723
- Butkiewicz AM, Kemona H, Dymicka-Biekarska V, Matowicka-Karna J, Radziwon P, Lipska A. Platelet count, mean platelet volume and thrombocytopoietic indices in healthy women and men. Thromb Res 2006; 118: 199–204